Phrontline Biopharma
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors. (NCT07778498) | Phrontline Biopharma | 2026-09-15 |
| A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors (NCT07181473) | Phrontline Biopharma | 2025-08-25 |
Track Phrontline Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.